Women who seek most forms of contraception do not need a routine pelvic examination before they are prescribed a contraceptive. Still, these exams are routine for many OB/GYN offices and reproductive health clinics, and this creates a barrier for some women — particularly those who have experienced sexual assault and intimate partner violence, according to new research.
This randomized, double-blind, placebo-controlled trial compared ceftriaxone (250 mg intramuscular once) and doxycycline (100 mg orally twice per day for 14 days) with and without metronidazole (500 mg orally twice per day for 14 days) for the treatment of pelvic inflammatory disease.
In this randomized, double-blind, controlled trial, routine treatment with metronidazole compared to placebo in addition to doxycycline and ceftriaxone reduced the presence of endometrial anaerobes, Mycoplasma genitalium, and pelvic tenderness at 30 days post-treatment. However, clinical improvement at three days post-treatment was no different between the two groups.
A technology-enhanced community health nursing intervention proved useful as a method for preventing gonorrhea and chlamydia infections. It also helped patients improve management of pelvic inflammatory disease.
In this cross-sectional national survey, the authors estimated that 23% of women aged 15 to 20 years had received a bimanual pelvic exam, of which half (54%) were deemed potentially unnecessary, and 19% of the population received a Pap test, of which 72% were potentially unnecessary.
Knowing the best way to counsel patients regarding the risks, benefits, and alternatives of performing an incontinence procedure at the time of reconstructive pelvic surgery for pelvic organ prolapse (POP) can be challenging.